42 results on '"Garmany, Ramin"'
Search Results
2. Abstract 4141293: Prognostic Significance of Exercise-Induced Ventricular Arrhythmia Patterns in PKP2-Mediated Arrhythmogenic Cardiomyopathy
Catalog
Books, media, physical & digital resources
3. Abstract 4137543: Prevalence, Genetic Correlates and Prognostic Significance of an Apical Pseudo-Infarct Late Gadolinium Enhancement Pattern in LMNA-Mediated Cardiac Laminopathy
4. A multi-omics atlas of sex-specific differences in obstructive hypertrophic cardiomyopathy
5. Proteomic and phosphoproteomic analyses of myectomy tissue reveals difference between sarcomeric and genotype-negative hypertrophic cardiomyopathy
6. Temporal Association Between Vaping and Risk of Cardiac Events
7. Frequency of and outcomes associated with nonadherence to guideline-based recommendations for an implantable cardioverter-defibrillator in patients with congenital long QT syndrome
8. Cardiopulmonary Exercise Testing in Athletes With Hypertrophic Cardiomyopathy
9. Abstract 17344: Risk Factors for Disease Severity in Cardiac Laminopathy
10. Abstract 17329: Histone Modifications Regulate Hypertrophy Pathways in Obstructive Hypertrophic Cardiomyopathy
11. Abstract 15291: Early Outcomes With Left Cardiac Sympathetic Denervation for Medically Refractory Idiopathic Ventricular Fibrillation
12. Abstract 13153: Proteomic Differences in Sarcomere Positive HCM May Explain More Severe Clinical Differences
13. Abstract 13141: Age of Onset and Clinical Outcomes in RBM20-Mediated Arrhythmogenic Dilated Cardiomyopathy
14. Abstract 12736: Cardiac Fludeoxyglucose-18 Positron Emission Tomography in Genotype-Positive Arrhythmogenic Cardiomyopathy
15. Histone Modifications and miRNA Perturbations Contribute to Transcriptional Dysregulation of Hypertrophy in Obstructive Hypertrophic Cardiomyopathy
16. A Multi-Omics Atlas of Sex-Specific Differences in Obstructive Hypertrophic Cardiomyopathy
17. BS-452759-1 SPATIAL CLUSTERING ANALYSIS HIGHLIGHTS DISEASE-SPECIFIC 3-DIMENSIONAL DISTRIBUTION OF PATHOGENIC VARIANTS IN THE -ENCODED NAV1.5 CARDIAC SODIUM CHANNEL
18. PO-02-142 MIRNA DOWN-REGULATE HYPERTROPHY AND INFLAMMATORY PATHWAYS IN THE TRANSCRIPTOME OF HYPERTROPHIC CARDIOMYOPATHY MYECTOMY TISSUE
19. BS-452758-3 SUPPRESSION-REPLACEMENT GENE THERAPY FOR -MEDIATED CARDIOMYOPATHIES
20. PO-04-143 CARDIOVASCULAR OUTCOMES IN -MEDIATED CARDIAC LAMINOPATHY: THE MAYO CLINIC EXPERIENCE
21. Clinical course of patients with hypertrophic cardiomyopathy away from tertiary referral care
22. RASopathy-Associated Cardiac Hypertrophy
23. Cardiac fludeoxyglucose-18 positron emission tomography in genotype-positive arrhythmogenic cardiomyopathy
24. Multi-Omic Architecture of Obstructive Hypertrophic Cardiomyopathy
25. Hypertrophic Cardiomyopathy Polygenic Risk Score Correlates with Genotype but Not Clinical Severity.
26. PO-704-01 CLINICAL COURSE OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AWAY FROM TERTIARY REFERRAL CARE
27. PO-704-02 VAPING-ASSOCIATED SUDDEN DEATH IN THE YOUNG
28. Red herring pathogenic variants: a case report of premature ventricular contraction-triggered ventricular fibrillation with an incidental pathogenic LMNA variant
29. PO-05-011 CLINICAL UTILITY OF PROTEIN LANGUAGE MODELS IN RESOLUTION OF VARIANTS OF UNCERTAIN SIGNIFICANCE IN KCNQ1, KCNH2, AND SCN5A COMPARED TO PATCH CLAMP FUNCTIONAL CHARACTERIZATION
30. PO-01-075 ROLE OF GENOTYPE IN RISK PREDICTION FOR ARRHYTHMOGENIC CARDIOMYOPATHIES
31. PO-01-188 A MULTI-OMIC COMPARISON OF SURGICAL MYECTOMY LEFT VENTRICULAR TISSUE REVEALS SEX-SPECIFIC DIFFERENCES IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
32. Prevalence and Prognostic Significance of Hypertrophic Cardiomyopathy Phenotype in PKP2-Mediated Arrhythmogenic Cardiomyopathy.
33. PO-04-143 CARDIOVASCULAR OUTCOMES IN LMNA-MEDIATED CARDIAC LAMINOPATHY: THE MAYO CLINIC EXPERIENCE
34. PO-03-143 PREVALENCE AND CLINICAL COURSE OF PEDIATRIC-ONSET ARRHYTHMOGENIC CARDIOMYOPATHY
35. BS-452759-1 SPATIAL CLUSTERING ANALYSIS HIGHLIGHTS DISEASE-SPECIFIC 3-DIMENSIONAL DISTRIBUTION OF PATHOGENIC VARIANTS IN THE SCN5A-ENCODED NAV1.5 CARDIAC SODIUM CHANNEL
36. BS-452758-3 SUPPRESSION-REPLACEMENT GENE THERAPY FOR LMNA-MEDIATED CARDIOMYOPATHIES
37. Temporal Association Between Vaping and Risk of Cardiac Events
38. Clinical Utility of Protein Language Models in Resolution of Variants of Uncertain Significance in KCNQ1, KCNH2 , and SCN5A Compared With Patch-Clamp Functional Characterization.
39. Magnetic Resonance Imaging Characterization and Clinical Outcomes of Dilated and Arrhythmogenic Left Ventricular Cardiomyopathies.
40. Histone Modifications and miRNA Perturbations Contribute to Transcriptional Dysregulation of Hypertrophy in Obstructive Hypertrophic Cardiomyopathy.
41. A Multi-Omics Atlas of Sex-Specific Differences in Obstructive Hypertrophic Cardiomyopathy.
42. Red herring pathogenic variants: a case report of premature ventricular contraction-triggered ventricular fibrillation with an incidental pathogenic LMNA variant.
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.